Aktienanalyse zu Precision Optics Corporation Inc (POCI)POCIPrecision Optics Corporation Inc

Precision Optics Corporation, Inc. is a developer and manufacturer of optical instruments. The Company’s segments include medical devices and advanced defense/aerospace products. Its optical and imaging technology, custom designs, manufacturing capabilities, and engineering and development capabilities have generated traditional endoscopes and endocouplers, digital imaging endoscopes using complementary metal-oxide-semiconductor (CMOS) sensor technology, some designed and manufactured for single-use, as well as other custom imaging and illumination products for our customers’ use in minimally invasive surgical procedures. It designs and manufactures precision endoscopes and microprecision lenses, assemblies and complete medical devices to meet the surgical community’s demand for imaging systems for minimally invasive surgery. Its technologies serve defense / aerospace markets, including applications supporting satellite network communications. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Precision Optics Corporation Inc (POCI) is a good buy right now due to its recent strong revenue growth of 107.1% year-over-year, with Q3 revenue reaching $8.7 million, and an upward revision of fiscal year 2026 revenue guidance to $29-$31 million. The current price of $4.40 is above the Fibonacci support level of $4.204, indicating potential for upward movement. However, the main risk is the negative net income of -$108,283 in Q3 2026, which highlights ongoing profitability challenges.